USRM

U.S. Stem Cell, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 8/21/2017
Contact Info
  • 13794 NW 4th Street
  • Suite 212
  • Sunrise, FL 33325

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2017 10-Q
CIK 0001388319
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8731 - Commercial physical research
Incorporated In: FL, USA
Year of Inc. 1999
Employees Not Available
Company Officers/Contacts
Miguel Tomas President, CEO
Kristin Comella CSO
Jill Arlene Robbins Counsel
Company Directors
William P. Murphy Jr., M.D. Chairman
Sheldon Anderson
Mark P. Borman
Company Notes
  • Formerly=Bioheart, Inc. until 11-2015
Service Providers
Accounting/Auditing Firm
Fiondella, Milone & LaSaracina LLP
300 Winding Brook Dr
Glastonbury, CT, 06033
United States

Legal Counsel
Jill Arlene Robbins, P.A.
525 93 Street
Surfside, FL, 33154
United States

Investor Relations Firm
Not Available
USRM Security Details
Share Structure
Market Value1 $12,316,072 a/o Dec 11, 2017
Authorized Shares 2,000,000,000 a/o Dec 08, 2017
Outstanding Shares 342,113,098 a/o Dec 08, 2017
-Restricted 52,369,577 a/o Dec 08, 2017
-Unrestricted 289,743,521 a/o Dec 08, 2017
Held at DTC 289,355,561 a/o Dec 08, 2017
Float Not Available
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
Continental Stock Transfer & Trust Company
Shareholders
Shareholders of Record 513 a/o Mar 15, 2017
Short Selling Data
Short Interest 51,300 (100%)
Nov 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security